Cargando…
Pharmacological Approaches to Modulate the Scarring Process after Glaucoma Surgery
Glaucoma is an acquired optic neuropathy that results in a characteristic optic nerve head appearance and visual field loss. Reducing the IOP is the only factor that can be modified, and the progression of the disease can be managed through medication, laser treatment, or surgery. Filtering procedur...
Autores principales: | Collotta, Debora, Colletta, Simona, Carlucci, Virginia, Fruttero, Claudia, Fea, Antonio Maria, Collino, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305204/ https://www.ncbi.nlm.nih.gov/pubmed/37375845 http://dx.doi.org/10.3390/ph16060898 |
Ejemplares similares
-
Recent advances in JAK inhibitors for the treatment of metabolic syndrome
por: Collotta, Debora, et al.
Publicado: (2023) -
Antisense oligonucleotides: a novel Frontier in pharmacological strategy
por: Collotta, D., et al.
Publicado: (2023) -
Pharmacological Inhibition of NLRP3 Inflammasome Attenuates Myocardial Ischemia/Reperfusion Injury by Activation of RISK and Mitochondrial Pathways
por: Mastrocola, Raffaella, et al.
Publicado: (2016) -
Minimally-invasive glaucoma surgeries (MIGS) for open angle glaucoma: A systematic review and meta-analysis
por: Lavia, Carlo, et al.
Publicado: (2017) -
The hidden role of NLRP3 inflammasome in obesity‐related COVID‐19 exacerbations: Lessons for drug repurposing
por: Bertocchi, Ilaria, et al.
Publicado: (2020)